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MutagenesisThe ﬂaviviral envelope (E) protein directs virus-mediated membrane fusion. To investigate membrane fusion
as a requirement for virus growth, we introduced 27 unique mutations into the fusion peptide of an
infectious cDNA clone of dengue 2 virus and recovered seven stable mutant viruses. The fusion efﬁciency of
the mutants was impaired, demonstrating for the ﬁrst time the requirement for speciﬁc FP AAs in optimal
fusion. Mutant viruses exhibited different growth kinetics and/or genetic stabilities in different cell types
and adult mosquitoes. Virus particles could be recovered following RNA transfection of cells with four lethal
mutants; however, recovered viruses could not re-infect cells. These viruses could enter cells, but
internalized virus appeared to be retained in endosomal compartments of infected cells, thus suggesting a
fusion blockade. Mutations of the FP also resulted in reduced virus reactivity with ﬂavivirus group-reactive
antibodies, conﬁrming earlier reports using virus-like particles.
Published by Elsevier Inc.Introduction
Dengue viruses (DENVs) are the leading cause of mosquito trans-
mitted viral disease in humans. An estimated 100million cases of dengue
fever and several hundred thousand cases of dengue hemorrhagic fever/
dengue shocksyndromeoccurworldwideeachyear (Gubler andMeltzer,
1999). There are 4 DENV serotypes (types 1–4) within the DENV
serocomplex of the genus Flavivirus, family Flaviviridae. Flaviviruses are
approximately 500 Å in diameter and possess a core composed of capsid
(C) proteins complexed with a single-stranded positive-sense RNA
genome of about 11 kb. The core is surrounded by a lipid bilayer
containing 180 copies of the envelope (E; 495 amino acids, AAs, for DENV
type 2, DENV2) protein arranged in rafts of 90 homodimers, and 180
copies of the membrane (M) protein (Kuhn et al., 2002).been formally disseminated by
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Inc.The E protein is a Class II fusion protein, essential for receptor
binding, membrane fusion, and inducing protective antibodies. The
crystal structures of the soluble E protein ectodomain in both pre- and
post-fusion states have been determined for tick-borne encephalitis
virus (TBEV) (Bressanelli et al., 2004; Rey et al., 1995) and DENV
(Modis et al., 2003, 2004, 2005; Zhang et al., 2004) (Fig. 1). The native
E protein monomer folds into three distinct domains (DI, DII, and
DIII), that correlate directly to the previously deﬁned antigenic
domains C, A, and B (Heinz, 1986; Mandl et al., 1989; Roehrig et al.,
1990). Domain I forms an 8–stranded β-barrel containing 2 insertion
loops and two α-helices that function as a molecular hinge for a low
pH-catalyzed E protein reorganization. Domain II contains the internal
fusion peptide (FP, AAs 98–111) at cd loop and reacts with antiviral
MAbs that are ﬂaviviral cross-reactive and potent inhibitors of virus-
mediated cell–membrane fusion. The AA sequence of the FP is highly
conserved among ﬂaviviruses. Domain III is a 10-stranded immuno-
globulin-like β-barrel with putative cellular receptor binding motifs
and elicits high titer virus-speciﬁc neutralizing antibodies.
Following attachment, the ﬂavivirion is internalized mainly via
receptor-mediated, clathrin-dependent endocytosis (Chu andNg, 2004;
Mosso et al., 2008; Suksanpaisan et al., 2009; vander Schaar et al., 2008).
The capsid escapes the endosome by fusion of the viral envelope and
endosomalmembrane via a lowpH-catalyzedoligomeric reorganization
of E protein homodimers to fusion-competent homotrimers (Bressanelli
et al., 2004; Kielian, 2006; Modis et al., 2004; Stiasny et al., 2004; Zhang
Fig. 1. Atomic structure of DENV2 envelope protein FP. (A) Top-view of E homodimer structure on mature virion. (B) Side-view of post-fusion E homotrimer structure. Structures of
the E homodimer (ID: 1oan) and post-fusion homotrimer (ID: 1ok8) were obtained from protein database bank and rendered by Polyview-3D (Porollo and Meller, 2007) to add
annotations. E protein domains are shown as DI-red, DII-yellow, and DIII-blue and the FP in DII are shown in magenta. The glycosyl chains of the E protein are not shown. The
homotrimer (B, right-side) was renderedwithmonomer-A in stick view, monomer-B in surface view, andmonomer-C in transparent surface view. Six amino acid residues on the top
hydrophobic rim of the FP targeted for mutagenesis in this study are marked with diamonds in the enlarged view.
306 C.Y.-H. Huang et al. / Virology 396 (2010) 305–315et al., 2004). Recent studies suggested that a conservedH residue is a pH
sensor that regulates rearrangement of the E domains for TBEV (Fritz et
al., 2008), and the membrane insertion of the FP occurs during the
dimer–trimer transition, preceding the ﬁnal hairpin-like homotrimer
(Stiasny et al., 2007b).
At least four experimental lines of evidence associate the ﬂaviviral
FP with fusion: (1) the ﬂaviviral FP is similar in AA sequence and
chemistry to the FP of other enveloped viruses; (2) acid treatment of
the virion resulting in oligomeric reorganization of the E protein
makes the FP accessible to anti-FP antibodies (Roehrig et al., 1990);
(3) structural analysis of post-fusion homotrimers predict the
convergence of three FPs at the tip of each homotrimer (Modis
et al., 2004); and (4) anti-DENV E protein-reactive MAbs that block
cell–cell fusion of virus-infected C6/36 cells react with the A1 epitope
that resides on a peptide spanning the ﬁrst 120 AA of the E protein
(Roehrig et al., 1998), and mapping to 3 AAs of FP by mutational
analysis of TBEV- and DENV-subviral particles (SVPs, also named
virus-like particles, VLP) (Allison et al., 2001; Crill and Chang, 2004).
Despite this evidence associating the FP with membrane fusion, direct
analysis to show involvement of speciﬁc FP AAs in the biochemistry of
membrane fusion has not been well-studied with whole ﬂavivirus
virions. Site-directed mutagenesis of the FP expressed on TBEV SVPs
has so far implicated only one residue, L107, in membrane fusion
(Allison et al., 2001), and the fusion mechanism could be different
from that observed with whole virions in subtle ways not yet deﬁned
because of differences in their structure and symmetry.
Cell–cell fusion of ﬂavivirus-infected C6/36 cells has been an
accepted classical experimental approach to measure ﬂavivirus Eprotein-mediated fusion activity (Gollins and Porterﬁeld, 1986a,1986b;
Guirakhoo et al., 1991, 1992, 1993; Kimura et al., 1986; Randolph and
Stollar, 1990; Roehrig et al., 1998; Summers et al., 1989). In this
approach, virions attached to cell surfaces (fusion-from-without, FFWO)
and/or viral E proteins incorporated into and expressed on the surface of
virus infected-cellmembranes (fusion-from-within, FFWI)mediate cell–
cell fusion at low pH. This labor-intensive fusion assay requires counting
of stained nuclei and cells to calculate a fusion index (FI).
More recently, an alternative approach to measure FFWO has been
developed for ﬂaviviruses. This approach uses pyrene-labeled ﬂavi-
virions or SVPs to fuse liposomes directly in a cell-free fusion system
(Allison et al., 2001; Corver et al., 2000; Heinz and Allison, 2000, 2003;
Stiasny et al., 2006, 2007a; Stiasny and Heinz, 2004). The post-fusion
reduction in ﬂuorescent signal is a direct measurement of membrane
fusion. This approach has some limitations, however. First, it requires
the production of concentrated, puriﬁed, pyrene-labeled virus,
an approach that is not practical when preparing a large number of
mutant DENV that often have reduced replication. Second, this
approach relies on passive virus–liposome interaction, and the
liposomes lack other components in cell membranes. Although
the exact fusion mechanism measured by the cell–cell and lipo-
somal fusion assays may be slightly different, it is clear that
both mechanisms depend on properties of the E-protein FP to effect
membrane fusion.
In this study, we have identiﬁed speciﬁc virion FP AAs essential for
cell–cell fusion. We accomplished this by introducing 27 unique AA
substitutions into the top hydrophobic rim of the FP, using a DENV2
infectious cDNA clone. The AAs mutagenized were selected using a
307C.Y.-H. Huang et al. / Virology 396 (2010) 305–315combination of sequence alignments, the 3-dimensional structure of
the DENV2 E protein (Fig. 1), and the chemical and structural
properties of the substituted residues. We evaluated the effects of
these mutations on viral replication in mosquitoes, mammalian and
mosquito cell cultures, on cell–cell fusion of virus-infected C6/36
cells, and on reactivity with E protein-speciﬁc MAbs.
Results
Design and construction of FP mutant viruses
The cd loop (AA 98–111) of the E-protein has long been predicted
to be the FP that mediates ﬂaviviral membrane fusion, based on its
conserved sequence, high G content, and AA sequence and chemical
composition similar to other known viral FPs (Seligman, 2008). This
loop is buried under DI and DIII of the paired E proteins in the
homodimer but is totally exposed at the top surface of the post-fusion
homotrimer (Figs. 1A and B) (Modis et al., 2004). In this study, we
made 27 mutated DENV2 infectious cDNA clones (Table 1) to deﬁne
the contribution of the top hydrophobic rim of the FP loop to fusion.
The top rim, consisting of the membrane anchoring residues W101,
L107 and F108, and the Gs at 102, 104, and 106 (Fig. 1B), has been
predicted to partially penetrate the endosomal membrane during
fusion (Modis et al., 2004).
The AA substitutions for G102, G104, and G106 were selected to
evaluate whether the lack of steric hindrance at these positions is
essential for maintaining FP loop structure and its fusion function
through the dimer–trimer rearrangement. Although a 104H in the FP
occurs naturally in the TBE complex viruses, the G104H mutation was
not selected for the study due to a previous report indicating that such
a mutation is lethal to DENV4 (Goncalvez et al., 2004). Mutations at
the tip of the hydrophobic rim (W101, L107, and F108) were designed
to determine the speciﬁc side-chain properties required for correct
membrane interaction. The overall contribution of the hydrophobicityTable 1
Recovery of viruses following transfection and passage-1 in Vero or C6/36 cells.









W101L +/+ wt −/− na
W101A −/− na −/− na
W101F +/− na −/− na
G102S +/+ mutant + S186S/P +/+ mutant
G104L −/− na +/+ G104S
G104S +/+ mutant +/+ mutant
G106W +/+ wt +/+ wt
G106S +/+ wt +/+ G106A
G106Q +/+ G106L +/+ G106L
G106A +/+ mutant +/+ mutant
G106L +/+ mutant +/+ mutant
L107A +/− na +/+ wt
L107F +/+ mutant +/+ mutant
L107Y +/+ wt −/− na
L107M +/+ wt +/+ mutant
L107T +/− na +/+ L107I
F108L +/+ wt +/+ wt
F108A +/− na −/− na
F108W +/+ mutant + F402L +/+ mutant
WF101/108FW +/− na −/− na
a The following deletion mutations were lethal in all cell types: W101del, L107del,
F108del, WL101/107del; WF101/108del; WLF101/107/108del; LF107/108del.
b Virus from transfected (V-0), or C-0/passage-1 (V-1 or C-1) seeds, detected by IFA
and RT-PCR.
c Genome sequence of mutant viruses: correct mutant genome (mutant), reverted to
wt (wt), recovered with different substitution at the mutation site, or contained the
mutation plus substitution shown at a different E protein residue in V-1 or C-1 seeds.
na: genome sequence is not available for lethal mutations.of W101, L107, and F108 to fusion was assessed with combinations of
single, double, and triple deletions. We reasoned that if these deletion
mutants were able to grow in certain host cells, it would suggest a
unique viral entry pathway not requiring a fusion step.
Mutant viruses derived from transfected vero cells
Nine mutations, W101A, G104L (Table 1), and all deletion
mutations (W101del, L107del, F108del, WF101/107del, WF101/
108del, WLF101/107/108del, and LF107/108del), were lethal. Eigh-
teen other mutant viral RNA (vRNA) transfected Vero cells expressed
detectable viral proteins and released viral genomes in medium (V-0)
(Table 1). Five of these mutants, W101F, L107A, L107T, F108A, and
WF101/108FW, however, could not be recovered from a subsequent
Vero cell passage (V-1). Thirteen viable V-1 viruses were recovered,
but full genome sequencing revealed that nine of these mutants were
unstable. Six of these unstable mutants, W101L, G106W, G106S,
L107M, L107Y, and F108L, reverted completely or partially to the wt
sequence. Mutant G106Q changed to G106L. Twomutants, G102S and
F108W, acquired additional mutations in their E genes, S186S/P and
F402L, respectively. Overall, only four mutants, G104S, G106A, G106L,
and L107F, had the expected full genomic sequences in harvested V-1
seeds. The G104S virus, however, grew poorly in Vero cells, resulting
in a very low progeny virus titer of 2.5 log10 TCID50/ml.
Mutant viruses derived from transfected C6/36 cells
Fourteen viable viruses were recovered following transfection
(C-0) and one passage in C6/36 cells (C-1) (Table 1). Three of these
viruses, G106W, L107A, F108L, reverted almost entirely to the wt
sequence. Four viruses, G104L, G106S, G106Q, and L107T, acquired
changes at themutated loci to S, A, L, and I, respectively. Sevenmutant
viruses, G102S, G104S, G106A, G106L, L107F, L107M, and F108W, had
the expected full-genome sequence in C-1 seeds, and were selected
for further phenotypic analyses. Since only two (G106A and G106L) of
these seven selected mutants could produce visible plaques in Vero
cells, we developed a C6/36 cell-based TCID50 assay to quantify
infectious virus in the seeds. The TCID50 assay using C6/36 cells was
generally more sensitive than the plaque assay using Vero cells; the
TCID50 titer of wt D2/IC-30P-NBX virus was about 0.5–1.0 log10/ml
greater than plaque assay titer.
Epitope mapping of mutant viruses
Changes in epitopes of the E protein for mutant viruses were
analyzed using awell-characterized panel of murineMAbs (Roehrig et
al., 1998) that identify all three domains of the E protein. Because seed
titers of some mutants were not high enough, we used indirect
ﬂuorescent antibody assay (IFA) with virus-infected C6/36 cells to
determine MAb binding (Table 2). Differences of four-fold or greater
in quantity of MAb bound at end-points when compared to wt virus
reactivity were considered signiﬁcant. Differences of this magnitude
were seen with only two mutants, G106A and G106L, in binding with
MAbs that deﬁne the DII epitope A1.
Growth kinetics of mutant viruses in C6/36, K-562, and Vero cell cultures
Twelve-day growth curves were carried out in C6/36, K-562, and
Vero cell cultures using D2IC-30P-NBX as the wt virus control. Viral
replication was followed by qRT-PCR of vRNA in the medium every
other day (data not shown), and peak infectious titers in medium of
each cell type were determined by TCID50 assay (Fig. 2A). Addition-
ally, we tested the temperature sensitivity of thesemutants by growth
in Vero cells at both 37 °C and 28 °C.
All stable mutants grew well in C6/36 cells with similar growth
curves, including peak titers at 10–12 days post infection (p.i.) similar
Table 2
Epitope mapping of DENV2 fusion peptide mutants.
Virus Monoclonal antibody reactivity (mean antibody concentration μg/ml at end-point)a
A1b A1 A3 A4 A5 C1 B1 B2 B4 prM
6B6C-1 4G2 1A5D-1 2H3 1B7-5 1B4C-2 3H5 9A3D-8 1A1D-2 2H2
30P-NBX 0.24 0.47 0.31 3.13 0.40 0.78 3.75 1.88 0.16 3.75
G102S 0.24 0.31 0.31 3.13 0.31 0.94 5.00 2.50 0.31 3.13
G104S 0.31 0.31 0.63 1.88 0.24 0.94 3.75 1.88 0.31 3.75
G106A 0.31 1.88 0.47 3.75 0.24 0.94 5.00 2.50 0.31 3.13
G106L N10.00 N10.00 0.31 3.75 0.20 0.94 5.00 1.88 0.31 3.13
L107F 0.47 1.25 0.31 3.75 0.24 0.94 3.75 2.50 0.31 3.75
L107M 0.47 0.63 0.47 3.75 0.24 1.88 3.75 2.50 0.31 3.75
F108W 0.24 0.31 0.31 1.88 0.24 0.94 5.00 1.88 0.16 3.75
a Antibody reactivity measured by IFA with low passage virus-infected C6/36 cells. Numbers are the endpoint concentration of puriﬁed antibody. Bolded number indicates equal
to or greater than 4-fold endpoint difference compared to wt virus.
b Murine MAbs and E protein epitopes were described previously (Roehrig et al., 1998).
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than the wt virus in mammalian cells. Growth of mutants G102S,
G104S, and F108W in mammalian cells was most different from theFig. 2. Peak replication titers of viral mutants and wt virus in C6/36, K-562, Vero cells
(at 37 °C and 28 °C), and A. aegypti RexD mosquitoes. (A) Virus growth was monitored
by qRT-PCR of cell culture medium every 2 days. Time points with peak viral RNA
concentrations were assayed for infectious titer by TCID50. ⁎Progeny viruses recovered
on day 12 p.i. with partial reversions (mixed population of wt and mutant sequences),
L107F (in Vero cells at 37 °C) and L107M (in all mammalian cell cultures). #Progeny
virus from G102S-infected K-562 cells had correct mutation, but acquired 2 prM
mutations (K51Q and T79R). Genomes of progeny viruses from C6/36 cells and viruses
with peak titers less than 3.6 log10 TCID50/ml in the experiment were not sequenced.
(B) Infection of adult mosquitoes was evaluated by IFA assay for DENV2 E protein in
head tissues 7 days post-IT inoculation. Each bar represents mean percent mosquitoes
infected in 3–5 replicates with 85-140 mosquitoes total. Chi-square analysis was used
to compare each mutant virus to 30P-NBX; ⁎p-valueb0.05.wt virus. Their growth in mammalian cells at 37 °C was reduced by 2
to more than 4.6 logs (G104S virus titer in K-562 cell culture was less
than the detection limit, 2.3 log10 TCID50/ml). When G102S virus was
grown in K-562 cells, mutations in prM51 (K51Q) and prM79 (T79R)
accumulated in day 12 samples of both replicates of the growth
kinetics experiment. The initial growth of G102S was very low for 8–
10 days, but increased suddenly at day 10, coinciding with acquisition
of prM mutations identiﬁed in day 12 samples. The 2 prM mutations
were not detected at earlier time points due to insufﬁcient vRNA for
sequencing, and their roles in virus replication were not analyzed
within this study. The G104S mutation permitted only minimal virus
growth in Vero cells at 37 °C, but it replicated to a titer of 4.6 log10
TCID50/ml without detectable reversion or compensatory mutations
when cultured at 28 °C.
Growth of both G106A and G106L mutant viruses was reduced in
Vero cells at 28 °C; however, replication kinetics of G106A in C6/36
cells at 28 °C, and K-562 and Vero cells at 37 °C were similar to the wt
virus. Mutant G106L had somewhat reduced growth in mammalian
cells compared to G106A and wt virus. The growth characteristics of
L107F and L107M were most similar to wt virus; however, genome
sequence analysis of virus in day 12medium revealed that L107M had
partially reverted to wt in both mammalian cell cultures. Although
partial reversion was also found in L107F virus grown in Vero cells at
37 °C, the mutation appeared to be stable in Vero cells at 28 °C. TheFig. 3. Percent fusion of mutant viruses relative to D2/IC-30P-NBX in C6/36 cell–cell
fusion assay. Triplicate wells of mock infected cells and D2/IC-30P-NBX infected
controls were included in each assay. Fusion with DIII mutant K305/307/310E was
included as an example for mutations engineered outside the fusion loop.
Fig. 4. Non-infectious fusion mutant particles. (A) Quantitative RT-PCR of negative strand DENV2 RNA inside of transfected Vero cells (V-0). (B) Quantitative RT-PCR of DENV2 RNA
in V-0 culture medium. (C) Quantitative RT-PCR of negative strand DENV2 RNA inside of Vero cells (V-1) infected with V-0 culture medium. (D) Quantitative RT-PCR of DENV2 RNA
in culture medium of V-1. RNA quantities below detectable limits were plotted on the X-axis for graphing purposes only.
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outcome of efforts at deriving these mutant viruses from vRNA-
transfected Vero cells (Table 1). In total, these results suggested that
the G102S, G104S, L107F, L107M, and F108W mutations caused
defective replication in mammalian cells, and the G104S as well as
L107F mutations decreased virus thermal stability at 37 °C.
Replication of mutant viruses in mosquitoes
To determine the ability of the seven C6/36 cell-infectiousmutants
to infect adult female A. aegyptimosquitoes, mutants were inoculated
intrathoracically (IT) intomosquitoes.With the exception of L107F, all
mutant viruses grew signiﬁcantly less efﬁciently than wt D2IC-30P-
NBX in RexD mosquitoes (Fig. 2B). Importantly, there appeared to be
no correlation between peak titers of themutant viruses in C6/36 cells
and proportion of mosquitoes infected in vivo.
Fusion activity of the mutant viruses
To assess the relevance of these mutations to fusion, we infected
C6/36 cells and measured virus-mediated fusion activity at pH 5.5 ina FFWI assay. Although the assay can be highly variable due to its
sensitivity to the concentration of the virus and/or E proteins
presented on the cell membrane at the time of fusion, we have
reduced possible assay variations by: (1) standardizing input virus at
MOI=0.1 and ﬁxing the time point p.i. for fusion assays, (2)
including positive (wt 30P-NBX virus) and negative (uninfected
cell) controls in each individual sample plate, and (3) normalizing all
positive control (53 total) results. Since these 7 mutants all have
similar replication kinetics as the wt DENV2 in C6/36 cells, the virus
and/or E protein quantities on the plasma membrane in the assay
should be similar. As seen in Fig. 3, the results had acceptable
variations and the reduction in fusion activity of the 7 fusionmutants
was evident when compared to the wt 30P-NBX virus control in each
assay. In contrast, other E-protein mutations (total of more than 20
mutants, data not shown) we engineered outside the FP caused no or
limited reduction in fusion activity using the same assay, indicating
the C6/36 cell–cell fusion assay can effectively measure the speciﬁc
fusion activity of each FP mutant. Mutant K305/307/310E (triple K-
to-E mutations in domain III) was included in Fig. 3 as a non-fusion
mutant example that has no fusion defect compared to wt control in
this assay.
Fig. 5. Structural components of wt and non-infectious mutant viral particles released
into transfected Vero cell culture medium. (A) Immunoblots of viral proteins detected
by DENV2 HMAF. (B) RT-PCR product (1.3 kb) ampliﬁed from RNase A-treated particles
using primers speciﬁc for DENV2-E-protein gene. Lane 1: D2/IC-30P-NBX wt virus;
Lane 2: WF101/108FW; Lane 3: W101F; Lane 4: L107A; and Lane 5: F108A. Lane M:
Pre-stained protein markers in (A), and DNA markers in (B); Lane N: negative control,
WLF101/107/208del. Lane T: RT-PCR result with RNaseA-treated in vitro transcribed
D2/IC-30P-NBX viral RNA (N1 μg total); used as naked vRNA control.
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Mutant viruses, W101F, L107A, F108A, and WF101/108FW,
showed ampliﬁcation of vRNA and viral antigen expression in V-0
transfections, but failed to produce virus that could initiate a second
round (V-1) of infection (Table 1). To conﬁrm the replication
competence of these mutants, we measured levels of negative-sense
(–) vRNA in V-0 cells (Fig. 4A) and vRNA in V-0 medium (Fig. 4B).
Following transfection, except for the lethal mutant WLF101/107/
108del (included as a negative control), levels of both forms of vRNA
of the four mutants increased at rates comparable to wt virus.
Genomic equivalent titers of W101F, L107A, F108A, WF101/8FW,
WLF101/7/8del, and D2IC-30P-NBX in the V-0 medium were 6.64,
5.73, 8.46, 6.02, 3.82, and 8.94 log10 copies/ml, respectively. We
infected fresh Vero cells with 1 ml of V-0 day 12 medium from each
mutant and again measured accumulation of intracellular (−)vRNA
and extracellular vRNA (Figs. 4C and D). None of the four mutants
could re-infect Vero cells.
To evaluate the protein composition of released particles in V-0
culture medium, pelleted particles concentrated by ultracentrifuga-
tion through a 20% sucrose cushion were analyzed by immunoblot-
ting, using antibodies reactive with DENV2 proteins. The DENV2 E and
prM proteins (∼50 and ∼22 kDa, respectively) could be detected
in every V-0 preparation except for mutant WLF101/107/108del(Fig. 5A). We were unable to detect M protein (∼8 kDa) in any of the
V-0 preparations (including wt virus), likely due to insufﬁcient
amounts. The C protein (∼12 kDa) of F108 and D2IC-30P-NBX virus
was readily detected by anti-C MAb 1A2A-1, but the C protein of the
other 3 mutant preparations could only be detected when using
samples concentrated from extremely high volumes in the assay (data
not shown). The intracellular E proteins of these four mutants were
also analyzed by IFA, using RNA-transfected Vero cells and the MAbs
described in Table 2. The W101F and WF101/108FW mutants lost
reactivity with both A1 MAbs, 6B6B-1 and 4G2. The L107A and F108A
mutants lost only 4G2 reactivity (data not shown).
In addition to the positive qRT-PCR results from the V-0 culture
medium (Fig. 4B), we were able to amplify larger cDNA fragments
(about 1.3 kb) by RT-PCR from secreted particles after RNase A
treatment, using both E gene-speciﬁc primers (Fig. 5B) and NS5 gene-
speciﬁc primers (data not shown). From our experience, cDNA
fragments larger than 1 kb cannot be readily ampliﬁed from degraded
vRNA templates. The large amounts of 1.3 kb E and NS5 cDNA
fragments ampliﬁed from the RNaseA-treated samples implied that
vRNA inside of the concentrated particles was mostly intact. Taken
together, our results suggest that even though complete virus
particles (containing viral proteins and vRNA) were present in V-0
culture media, these mutant viruses were not able to initiate a second
round of infection.
In multiple transfection experiments, we consistently found that
mutant F108A released virus particles at the same or slightly lower
levels as the D2IC-30P-NBX virus. Although similar amounts of
mutant vRNA were used in initial transfections, quantities of the
secreted non-infectious L107A, W101F, and WF101/8FW viral
particles were generally lower than mutant F108A, suggesting that
some of these mutations may also decrease the efﬁciency of viral
protein processing and particle assembly/release.
Mutation F108A blocked viral fusion with endosomal membranes
To better characterize the lesions in these non-infectious mutant
viral particles, we selected mutant F108A for further study because it
produced sufﬁcient amounts of virus particles following transfection
of Vero cells. Vero cells grown in chamber slides were exposed to
concentrated F108A viral particles fromV-0, and at 2 h p.i., F108A viral
antigens were seen in speckled patterns inside cells (Fig. 6A). The
number of mutant F108A-positive cells with speckled staining
decreased signiﬁcantly at 4 h p.i. and was further reduced between
4 and 12 h p.i.. All mutant F108A-exposed cells were negative for
antigen expression at 24 h p.i. (data not shown). In contrast, D2IC-
30P-NBX wt control virus-infected cells showed a diffuse staining
pattern that increased progressively between 2 and 12 h p.i. (Fig. 6B).
The total number of wt-infected IFA positive cells also increased
throughout the 12-h time-course, indicating efﬁcient viral replication
and spread. We generally observed 40–70% IFA positive wt-infected
cells at 12 h p.i. and over 90% positive at 24 h p.i. (not shown).
Double-staining experiments were also performed at 2 and 4 h p.i.,
using DENV2 hyperimmune mouse ascitic ﬂuid (HMAF) and anti-
early endosome marker protein-1 (EEA-1) MAb, or DENV2 HMAF and
anti-lysosomal-associated membrane protein-2 (LAMP-2) MAb to
determine the location of viral antigens in the infected cells. EEA-1 is a
membrane protein of early endosomes and LAMP-2 proteins are
present in both late endosomes and lysosomes. The majority of
internalized F108A viral antigen co-localized with the EEA-1 protein
(Fig. 6C) and/or LAMP-2 (not shown) at 2–4 h p.i., indicating that
mutant F108A was able to enter endosomes through endocytosis, but
unable to escape from the endosomal and lysosomal compartments.
Failure to escape endosomes is likely a result of a defect in fusion. In
contrast, the internalized D2IC-30P-NBX viral antigens were detected
not only in association with endosomal vesicles, but also outside
endosomes by 2 h pi (Fig. 6D).
Fig. 6. IFA staining of Vero cells infected with (A) concentrated mutant F108A, or (B) D2IC-30P-NBX particles. DENV2 HMAF was used for staining at 2 h, 4 h, 6 h, and 12 h p.i.
Co-localization of (C) mutant F108A or (D) D2IC-30P-NBX antigens with early-endosomes in cells stained at 2 h p.i. with DENV2 HMAF (green) and anti-EEA-1 (red). Cells in (C) and
(D) were examined by confocal microscopy at 1000×, and scale bars of 10 μm are shown.
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This study provides direct evidence that multiple AAs at the top
rim structure of a ﬂaviviral FP regulate the biochemistry of virus–membrane fusion and subsequently affect viral growth characteristics
in cell cultures andmosquitoes. AA substitutions in various residues of
the FP tip abrogate or severely impair the fusion capacity of mutant
viruses, resulting in either a lethal mutation, non-infectious virus
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mosquitoes. We also characterized the biochemistry of 6 FP residues
that are required for productive membrane fusion in virus replication.
AAs without a side chain (G) or with a small side chain (S) at
positions 102 and 104 appeared to be critical for maintaining FP
structure and fusion activity. Both G102S and G104S mutants reacted
with a panel of MAbs against various E epitopes at similar levels as the
wt virus (Table 2), demonstrating minimum perturbation of E
antigenic structure. Substitution by S caused minimal effects in viral
infection of C6/36 cells, but reduced infection in Vero and K562 cells.
Although we recovered low titers of the G104S mutant virus with
correct genome sequence from Vero cells (Table 1), comparison of
growth kinetics at 37 °C and 28 °C indicated that the G104S change
decreases viral thermal stability (Fig. 2A). Change of G104 to a large
hydrophobic side chain, L, is lethal in Vero cells, and virus recovered
from C6/36 cells had evolved to G104S within a single cell passage,
indicating strong selection pressure against the 104L substitution.
Residue G106 is somewhat more tolerant of substitutions with
small to medium hydrophobic side chains. Nevertheless, substitutions
for G106 of small polar (S), large polar (Q), or large non-polar (W)
residues resulted in recovered virus with a G-reversion, L, or A
mutation at 106, respectively. The rapid evolution from engineered
G106Q to 106L observed in multiple experiments resulted from a
nucleotide transversion from CAA to CUA, indicating strong selection
against the Q substitution. Interestingly, recombinant VLPs containing
the G106Qmutation were previously recovered from cells transfected
with plasmids carrying the prM-E genes of DENV2 or St. Louis
encephalitis virus (SLEV) (Crill and Chang, 2004; Trainor et al., 2007),
indicating that the Q mutation did not have a negative impact on later
events in viral replication such as protein translation, processing, and
subviral particle assembly/release. On the contrary, higher G106Q
mutant VLP secretion than wt VLP was observed, suggesting that the
mutation was favorable for E protein processing and VLP assembly/
release. The live virus replication block caused by G106Q substitution
likely occurs prior to protein translation. The crystal structure of E
indicates a hydrogen-bond (H-bond) between the main-chain
carbonyl oxygen of G106 and the indoleamine of the W101 side-
chain, and this H-bond permits W101 to penetrate completely into
the hydrocarbon layer of membrane lipids (Modis et al., 2004) and is
likely critical for effective membrane fusion. The hydroxyl on the side-
chain of S and the amines on the side-chains of W and Q, when
substituted for G106, could adversely affect formation of the correct
101–106 H-bond needed for membrane fusion; the A or L evolution
found in recovered viable virus might allow the correct H-bond. Not
only were the evolved G106A and G106L mutant viruses recovered
during attempted derivation of the G106W or G106Q mutants, we
also successfully derived the G106A and G106L mutants from
engineered mutant cDNA clones. Both mutants were viable in C6/36
and Vero cells, but growth kinetics indicated that A substitution is
preferable to L for growth in K562 and Vero cells. Mutant G106A had
decreased binding to only MAb 4G2, while mutant G106L had
decreased binding to both MAbs 6B6C-1 and 4G2 (both interact
with the A1 epitope), suggesting that the substitution of L with a
larger side-chain affected the overall A1 epitope conformation more
than the A substitution.
The predicted fusion model suggests that the top hydrophobic rim
of the FP forms a bowl-like concavity in the post-fusion homotrimer,
and the hydrophobic W101, L107, and F108 on the rim anchor the FP
to the endosomal membrane during fusion (Modis et al., 2004). The E
trimers penetrate about 6 Å into the target membrane and the
exposed carbonyls and charged residues on the outside rim of the
fusion bowl prevent further penetration. Our single, double, and
triple deletion mutants at W101, L107, and F108 were lethal in both
C6/36 and Vero cells, demonstrating that all 3 membrane anchors on
the top rim of the FP are required for infection in both cell types.
These results support recent evidence that receptor-mediated,clathrin-dependent endocytosis and subsequent acid-dependent
viral envelope-endosome membrane fusion constitute the major
entry pathway for DENV2 infection in both cultured mosquito and
mammalian cells (Acosta et al., 2008; Krishnan et al., 2007; van der
Schaar et al., 2008). In addition, we found the aromatic W101 can not
be replaced with non-polar AA (such as A and L), or another aromatic
AA, F. Size, shape, and chemical properties of the hydrophobic side-
chains can inﬂuence their biochemical interactions with lipid bilayers
(MacCallum et al., 2008). TheW is themost interfacial-active AA in the
membrane, and has a strong tendency to align its aromatic ring with
the lipid hydrocarbon tails and point its polar portion toward the lipid-
water interface. Our results suggest that effective fusion requires
precise membrane anchoring by W101, including correct orientation
and penetration depth, and provide experimental evidence that
supports the fusion model predicted from the crystal structure.
Substitution of hydrophobic L107 by hydrophobic F or M resulted
in viable mutant viruses from C6/36 cells. However, L107M is not
stable in Vero cells and L107F is less thermo-stable at 37 °C. It was not
surprising to recover viable mutant L107F, since F107 is found in tick-
borne Powassan virus and a Japanese encephalitis SA-14-14-2 vaccine
virus (Ni et al., 1995). An engineered L107F mutant West Nile virus
(WNV) was also viable but resulted in mouse attenuation (Zhang
et al., 2006). Change of L107 to the smaller hydrophobic A, small
hydrophilic T, or large hydrophilic Y was lethal in Vero cells, and the
virus recovered from C6/36 cells either reverted to wt or changed to I,
which has very similar properties to the wt L. We propose that a
hydrophobic AA with a large side-chain is required for residue 107,
and L is preferred for DENV2 infection of mammalian cells.
Mutagenesis at F108 revealed that a hydrophobic AA with a large
aromatic side chain at this position is critical for FP function.
Substitution with hydrophobic residues such as A and L yielded lethal
mutations. On the other hand, mutant F108W virus was recovered
and replicated well in C6/36 cells, but it did not replicate in
mammalian cells unless additional mutations evolved during culture.
We recovered non-infectious viral particles from V-0 preparations
after introduction of W101F, L107A, F108A, or WF101/108FW
mutations. Using confocal IFA with double staining, we observed
that non-infectious mutant F108A particles entered cells through the
endocytosis pathway, but the internalized particles appeared to be
trapped in endosomal compartments. Unable to effectively fuse from
within endosomes, the mutants were likely degraded in late-
endosomes or lysosomes (Luzio et al., 2007) before capsid could be
released into the cytoplasm to initiate subsequent replication.
Successful ﬂavivirus-mediated fusion takes only seconds (van der
Schaar et al., 2008) after virus entry; our results are the ﬁrst to
demonstrate that mutations in the FP blocked virus escape from
endosomes for several hours. We suspect similar blocks also occurred
with the other non-infectious mutants, W101F, L107A, and WF101/
108FW upon V-1 passage. Other lethal mutations that did not yield
detectable non-infectious particles from RNA-transfected cell cultures
may have additional defects in the later events of viral replication
such as E protein folding to form prM-E heterotrimers during virus
assembly and maturation. We found that F108A consistently yielded
more virus particles than the other three non-infectious mutants,
supporting the theory that some substitutions in the FP could have
effects in E protein processing and/or viral assembly. This is
consistent with previous observations that mutations at G104, G106
and/or L107 of the VLP of SLEV andWNV resulted in alterations in VLP
secretion (Crill et al., 2007; Trainor et al., 2007). E proteins expressed
by six mutants, including both infectious and non-infectious virus
particles, had decreased binding to the ﬂavivirus group-reactive MAb
4G2. Three mutants also had altered conformations of the A1 epitope
for MAb 6B6C-1. The differences in MAb binding activities between
F108W (no effect) and F108A (reduced binding to bothMAbs), as well
as between G106A and G106L (Table 1), indicated different effects of
particular AAs on the conformation of the A1 epitope.
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mutants or non-infectious particles in both mammalian and mosquito
cells, suggesting that virus–endosome fusion is essential for ﬂavivirus
infection in both cell types. In addition, our results demonstrate that
the threshold for productive fusion in DENV2 replication may be
different among cultured mosquito C6/36 cells, cultured mammalian
cell lines, and live mosquitoes. Although fusion assays of the mutants
clearly showed reduced fusion efﬁciency caused by the 7 viable FP
mutations, their replication in C6/36 cells was not affected. However,
the fusion reduction appeared to affect the replication of some in
mammalian cells and mosquitoes. This ﬁnding also indicates
successful DENV infection of C6/36 cells does not necessarily reﬂect
viral infectivity for mosquitoes. Although this study did not
completely deﬁne all possible mechanisms that caused differences
in replication among various cell cultures and mosquitoes, our results
showed that lower thermo-stability at 37 °C than at 28 °C of mutants
G104S and L107F could partly contribute to the difference in virus
viability betweenmammalian (cultured at 37 °C) and C6/36 (cultured
at 28 °C) cells. Other cellular differences among the cell types could
also affect mutant virus replication efﬁciency. It is possible that the
intracellular environment of the cultured C6/36 cells provided a
lower threshold requirement for productive fusion that could bemore
easily overcome by some FP mutants, while the intracellular
composition/compartments of Vero and K562 cells required more
optimal fusion chemistry for productive membrane fusion to
efﬁciently release the viral capsid into cytoplasm. There are
contradictory reports regarding the type of endosomes and intracel-
lular trafﬁcking involved in the ﬂavivirus–endosome fusion in various
cell types. Some studies suggested DENV and WNV fusion takes place
in early endosomes and viral infection does not require transportation
of the virus from early to late endosomes (Chu et al., 2006; van der
Schaar et al., 2008), others demonstrated that ﬂaviviruses mainly
initiated fusion in late endosomes and perturbation of microtubule
trafﬁcking of early to late endosomes tremendously reduced virus
replication (Acosta et al., 2008; Krishnan et al., 2007). From these
reports and our results, it is apparent that the fusion activity of
ﬂaviviruses is regulated by not only the fusion peptide and structural
features of the E protein, but also the microenvironment in the cells,
including the trafﬁcking and maturation pathway of endocytic
vesicles, the pH of the endosomes, and temperature at which the
host cells were grown. Subtle differences can change the dynamics of
viral endocytosis and fusion activity, and the conservation of the AA
sequence of the ﬂavivirus fusion peptide of is a result of optimization
to infect both mammalian hosts and mosquito vectors.
It is beyond the scope of this study to deﬁne all possible
mechanisms that contribute to the differences in replication of the
DENV2 fusion mutants in various cell types, but it is notable that even
wt DENV2 typically replicates more efﬁciently and to higher titers in
C6/36 cells than in Vero or other mammliam cells. A recent study
investigating Japanese encephalitis virus (JEV) entry into C6/36 cells
also bears on our ﬁndings (Nawa et al., 2007). The results of this study
suggest that: (1) JEV can enter C6/36 cells by fusion at the cell surface,
resulting in a productive infection even in the presence of baﬁlomycin
A1, an inhibitor of cellular endocytosis; (2) this entry mechanism into
C6/36 cells is pH-dependent—indicating that the oligomeric reorga-
nization of the E protein is necessary for infection; however, (3) in C6/
36 cells, it is not a strict requirement for virus to be in contact with or
close proximity to membranes at the time of the low pH reorgani-
zation for membrane fusion to occur, as is the case for fusion of
endosomal membranes or liposomes. Additionally, the actual location,
amount, and conformation of E protein expressed on the virus-
infected cell surface and available to participate in cell–cell fusion is
not well deﬁned. Our set of FP-mutant DENVs will be useful in
determining whether or not these observations are also true for DENV
and what the speciﬁc AA composition of the FP needs to be for this
type of infectivity in C6/36 cells to occur. Future detailed studies ofmutant viral infection in the presence of various endosomal
trafﬁcking/maturation inhibitors in different cell types may provide
further knowledge in this area.
Materials and methods
Cell cultures
Vero and K562 (mammalian) cells were grown at 37 °C, and C6/36
(Aedes albopictus mosquito) cells were grown at 28 °C in modiﬁed
minimum essential medium (DMEM) containing 10% fetal bovine
serum (FBS). DMEMandYE-LAHmedia used for virus propagation and/
or growth kinetics have been described previously. (Huang et al., 2000).
Site-directed mutagenesis, construction of infectious cDNA clones,
and recovery of mutant viruses
A DENV2 strain 16681 infectious cDNA plasmid, pD2IC-30P-NBX,
was modiﬁed from pD2IC-30P-A (Kinney et al., 1997). The modiﬁed
plasmid contains silent mutations for introduction of unique cloning
sites. The clone-derived virus, DENV2 30P-NBX, exhibits the same
phenotypes as the DENV2 16681 virus and was used as wt control
virus. Site-directed mutagenesis generating the mutant cDNA clones
was performed with a Quick Change Site-directed Mutagenesis kit
(Stratagene).
Positive-sense vRNA transcribed in-vitro from full-length cDNA
(Huang et al., 2000, 2003), was electroporated into Vero (4×106
cells/0.4 ml) or C6/36 (8×106 cells/0.4 ml) cells, using a BioRad Gene
Pulser Xcell system, and cells were incubated in 75 cm2 ﬂasks. Cell
culture medium (designated V-0 seed from Vero cells and C-0 seed
from C6/36 cells) was harvested 10–14 days post-transfection, and an
aliquot was used to infect fresh Vero or C6/36 cells to produce
working seeds (V-1 or C-1). Full-length genomes of working seeds
were sequenced to verify consensus sequences (Table 1). Viral antigen
in transfected or infected acetone-ﬁxed cells was detected by IFA
using polyclonal anti-DENV2 New Guinea C (NGC) HMAF and
ﬂuorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG
(Jackson Immunoresearch Laboratories). Reverse transcription-PCR
(RT-PCR) was used to detect the presence of virus genomes in culture
medium and for viral genome sequencing. Viral RNA was extracted
using the QIAamp Viral RNA Kit (Qiagen), and ampliﬁed using the
Titan One Tube RT-PCR Systems Kit (Roche Applied Science).
Concentration and analysis of virus particles
Day 12 culture medium from transfected Vero cells was ultra-
centrifuged through a 20% sucrose cushion at 82,700 RCF for 18 h at
4 °C. The pellet was resuspended with 100 μl PBS and stored at
−70 °C. To remove any possible co-sedimenting free vRNA in the
pelleted samples, they were treated with RNaseA. In vitro transcribed
D2IC-30P-NBX vRNAwas used as naked-RNA control and treated with
the same concentration of RNaseA to verify 100% removal of free RNA.
RNA protected in the pelleted particles was then extracted and
detected by RT-PCRwith speciﬁc DENV2 E gene and NS5 gene primers
that produce amplimers greater than 1 kb. To detect viral proteins,
pelleted samples were separated by SDS-PAGE on a 4–12% bis-Tris gel
with MOPS or MES buffer (Invitrogen). Proteins were blotted onto
PVDF membranes and detected using the Western Breeze kit
(Invitrogen) and primary antibodies speciﬁc to DENV2 proteins
(DENV2 HMAF), DENV2-E protein (MAb 3H5), and DENV2-C protein
(MAb 1A2A-1).
Fifty percent tissue culture infectious dose (TCID50) assays
Because some mutant viruses did not replicate or form plaques in
mammalian cell cultures, we developed an ELISA-based TCID50 assay
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C6/36 cells in 96-well plates were infected with 10-fold serial virus
dilutions in triplicate. Following 12 days of incubation at 28 °C, the
cells were ﬁxed with acetone and viral antigens were detected by
enzyme-linked immunosorbent assay using DENV2 HMAF. TCID50
titer was calculated using the method of Reed and Muench.
Growth of mutant viruses in cell cultures
Viral growth curves were performed by infection of duplicate Vero,
K-562, and C6/36 cell cultures at a multiplicity of infection (MOI) of
0.001 TCID50. Aliquots of culture medium were harvested every other
day for 12 days and vRNA was extracted and measured by
quantitative RT-PCR (qRT-PCR) (Butrapet et al., 2006). The sample
with peak qRT-PCR titer was subjected to TCID50 assay for infectious
virus titers. The vRNA extracted from day 12 samples was subjected to
structural gene sequencing.
Viral replication in Aedes aegypti mosquitoes
A. aegypti (RexD) laboratory colony mosquitoes originating from
Puerto Rico were reared at 28 °C, 80% relative humidity with a
photocycle of 12 h light: 12 h dark. Adult female mosquitoes 5–6 days
post-emergence were IT inoculated with approximately 0.3–0.5 μl
(30–50 TCID50) viral C-1 seed or culture medium and maintained for
7 days, when heads of injected mosquitoes were removed and ﬁxed
onto slides with cold acetone. DENV2 E antigen was detected by IFA
with DENV2 MAb 3H5, biotinylated sheep anti-mouse IgG, and
streptavidin–ﬂuorescein (Amersham Biosciences).
Cell–cell fusion of C6/36 cells (fusion from within, FFWI)
Fusion activity of mutants was measured by quantitating cell–cell
fusion of virus-infected C6/36 cells (Guirakhoo et al., 1993). Brieﬂy, C6/
36 cells in 24-well plateswere infected at aMOI=0.1 andmaintained in
pH 7.7 culture medium at 28 °C and 5% CO2. At 7 days p.i. mediumwas
replaced by fusionmediumbufferedwithMES to pH 5.5 for 2 h at 28 °C.
Cells were returned to pH 7.7 medium for 24 h incubation and stained
with Hema-3 quick stain (Fisher). Numbers of cells and nuclei in each
well were counted (at least 5microscopicﬁelds perwell) for calculation
of fusion index, FI=1−(number of cells/number of nuclei) and
percent fusion=(mean FI for each mutant/wt control mean FI; n=58
for wt control accrued throughout thewhole study). The percent fusion
of thewt virus and non-infected cell controls in eachmutant virus assay
were included to standardize results. Results were derived from 2 to 3
independent assays of each mutant virus.
Quantiﬁcation of negative-sense vRNA
To avoid false priming in the RT-PCR assay for (−)vRNA (Peyreﬁtte
et al., 2003), we developed a 2-step RT-qPCR using tagged primers.
DENV2 primers and probes selected for the assay were from the 3′non-
coding genome region (Houng et al., 2001). A 19-nt Tag sequence
(Peyreﬁtte et al., 2003) with no homology to DENV2 vRNA sequence
was added to the 5′-end of the DENV2 primer, T-D2-10551, used for RT.
For RT, template RNAswere denatured at 65 °C for 5min in the presence
of 1 μMT-D2-10551primer and0.6mMdNTPmix. First strand synthesis
buffer containing 50 units of Superscript III (Invitrogen) and 5 units of
RNase out (Invitrogen) was added and the reaction was carried out at
50 °C for 30 min. Excess RT primers were removed by PCR puriﬁcation
kit (Qiagen), and ampliﬁed cDNA were quantiﬁed by qPCR using the
iQ™ Supermix kit (BioRad)with 0.4 μMprimers (Tag-primer containing
only the 19-nt Tag and DENV2 primer CD2-10703), and 2 μM DENV2
probe (D2-10656P) in an iCycler iQ5 (BioRad) with the following
protocol: 95 °C for 10 min followed by 45 cycles of 95 °C for 15 s and
60 °C for 1 min. In vitro transcribed (−)vRNA from a speciﬁcally-constructed plasmid containing the primer/probe-target DENV2 cDNA
fragment was quantiﬁed and serially diluted to generate a standard
curve for the 2-step RT-qPCR.
Determination of non-infectious mutant RNA replication in cells
Vero cells were electroporated with lethal mutant vRNAs, and each
sample was separated intomultiple 25-cm2 ﬂasks for culturing. At 6, 24,
and 48 h post-transfection, 300 μl of culture medium (V-0) was saved
and cells were harvested by trypsinization. Culture medium was also
harvested on day 12; 1mlwas used to infect freshly conﬂuent Vero cells
(V-1), and remaining medium were subjected to sucrose cushion
ultracentrifugation. Cells and aliquots of medium (V-1) were also
harvested from the freshly infected Vero cells at 2, 8, 24, and 48 h after
infection.
Total RNA was extracted from the harvested cells and (−)vRNA
was quantitated by the 2-step (−)vRNA speciﬁc RT-qPCR. vRNA in
harvested V-0 and V-1 was quantitated by 1-step qRT-PCR (Butrapet
et al., 2006). Rates of increase of intracellular (−) vRNA and
extracellular vRNA were compared for mutant and wt viruses using
non-linear regression curves and asymptotic regression models.
Confocal immunoﬂuorescent microscopy
Vero cells in 16-well-chamber slides were infected with concen-
trated D2IC-30P-NBX or mutant F108A virus particles prepared from
RNA-transfected Vero cell cultures. At various time points, cells were
washed with PBS and ﬁxed with acetone. DENV2 antigen was
detected with DENV2-HMAF and FITC-conjugated goat anti-mouse
IgG. Rabbit anti-EEA-1 and anti-LAMP-2 antibodies (Abcam), and
Texas red-conjugated goat anti-rabbit IgG were used to locate early
endosomes and late endsomes/lysosomes, respectively. Cells were
examined with a Ziess LSM5 confocal microscope.
Antigenic characterization of mutant E proteins
E protein reactivity of a panel of DENV MAbs (Roehrig et al., 1998)
was performed by IFA assay with acetone-ﬁxed virus-infected C6/36
cells or RNA- transfected Vero cells. Results were reported as average
(n=3–4) endpoint puriﬁed MAb concentrations (Table 2).
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